Characterization of seven new HLA alleles, A*24:14:01:04, A*29:02:01:07, C*06:02:01:37, C*07:830, C*16:162, C*16:01:01:07 and DQA1*01:02:05.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
12 2019
Historique:
received: 05 09 2019
accepted: 06 09 2019
pubmed: 11 9 2019
medline: 2 6 2020
entrez: 11 9 2019
Statut: ppublish

Résumé

Seven new HLA alleles were characterized by next generation sequencing in the Spanish population.

Identifiants

pubmed: 31502401
doi: 10.1111/tan.13687
doi:

Substances chimiques

HLA-A Antigens 0
HLA-A*29:02 antigen 0
HLA-A24 Antigen 0
HLA-C Antigens 0
HLA-C*06:02 antigen 0
HLA-C*16 antigen 0
HLA-DQ alpha-Chains 0
HLA-DQA1 antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

521-522

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.
Robinson J, Halliwell JA, Hayhurst JD, Flicek P, Parham P, Marsh SG. The IPD and IMGT/HLA database: allele variant databases. Nucleic Acid Res. 2015;43:D423-D431.
Saper MA, Bjorkman PJ, Willey DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol. 1991;219:277-319.

Auteurs

Dolores Planelles (D)

Histocompatibilidad, Centro de Transfusión de la Comunidad Valenciana, Valencia, Spain.

Antonio Balas (A)

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.

Manuel Rodríguez-Cebriá (M)

Histocompatibilidad, Centro de Transfusión de la Comunidad Valenciana, Valencia, Spain.

Miguel A Moreno-Hidalgo (MA)

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.

José L Vicario (JL)

Histocompatibilidad, Centro de Transfusión de la Comunidad de Madrid, Madrid, Spain.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH